Topper David Joseph

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Topper David Joseph's trades of Arcutis Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
295.76
Quantity 54,527
Value US$1,844,679
Transaction date
Proposed sale
Price
62.83
Quantity 99,195
Value US$682,426
Transaction date
Proposed sale
Price
15.80
Quantity 9,600
Value US$151,698
Transaction date
Proposed sale
Price
9.48
Quantity 11,626
Value US$110,264
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-08 2025-08-08
PrS Proposed sale
54,527
295.76
US$1,844,679 		54,527 295.76 US$1,844,679
2025-08-06 2025-08-06
PrS Proposed sale
99,195
62.83
US$682,426 		99,195 62.83 US$682,426
2025-04-03 2025-04-02
S Sale
52,290 +28.9%
416.95
US$4,132,933 		52,290 +28.9% 416.95 US$4,132,933
2025-04-02 2025-04-02
PrS Proposed sale
9,600
15.80
US$151,698 		9,600 15.80 US$151,698
2024-09-25 2024-09-24
S Sale
11,626 -6.8%
9.48
US$110,264 		11,626 -6.8% 9.48 US$110,264
2024-09-24 2024-09-24
PrS Proposed sale
11,626
9.48
US$110,264 		11,626 9.48 US$110,264